These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Fast fragment and compound screening pipeline at the Swiss Light Source. Stegmann DP; Steuber J; Fritz G; Wojdyla JA; Sharpe ME Methods Enzymol; 2023; 690():235-284. PubMed ID: 37858531 [TBL] [Abstract][Full Text] [Related]
6. Fast fragment- and compound-screening pipeline at the Swiss Light Source. Kaminski JW; Vera L; Stegmann DP; Vering J; Eris D; Smith KML; Huang CY; Meier N; Steuber J; Wang M; Fritz G; Wojdyla JA; Sharpe ME Acta Crystallogr D Struct Biol; 2022 Mar; 78(Pt 3):328-336. PubMed ID: 35234147 [TBL] [Abstract][Full Text] [Related]
7. MeshAndCollect: an automated multi-crystal data-collection workflow for synchrotron macromolecular crystallography beamlines. Zander U; Bourenkov G; Popov AN; de Sanctis D; Svensson O; McCarthy AA; Round E; Gordeliy V; Mueller-Dieckmann C; Leonard GA Acta Crystallogr D Biol Crystallogr; 2015 Nov; 71(Pt 11):2328-43. PubMed ID: 26527148 [TBL] [Abstract][Full Text] [Related]
8. Advantages of crystallographic fragment screening: functional and mechanistic insights from a powerful platform for efficient drug discovery. Patel D; Bauman JD; Arnold E Prog Biophys Mol Biol; 2014; 116(2-3):92-100. PubMed ID: 25117499 [TBL] [Abstract][Full Text] [Related]
9. A linear relationship between crystal size and fragment binding time observed crystallographically: implications for fragment library screening using acoustic droplet ejection. Cole K; Roessler CG; Mulé EA; Benson-Xu EJ; Mullen JD; Le BA; Tieman AM; Birone C; Brown M; Hernandez J; Neff S; Williams D; Allaire M; Orville AM; Sweet RM; Soares AS PLoS One; 2014; 9(7):e101036. PubMed ID: 24988328 [TBL] [Abstract][Full Text] [Related]
10. Fragments as Novel Starting Points for tRNA-Guanine Transglycosylase Inhibitors Found by Alternative Screening Strategies. Hassaan E; Eriksson PO; Geschwindner S; Heine A; Klebe G ChemMedChem; 2020 Feb; 15(3):324-337. PubMed ID: 31808981 [TBL] [Abstract][Full Text] [Related]
11. F2X-Universal and F2X-Entry: Structurally Diverse Compound Libraries for Crystallographic Fragment Screening. Wollenhaupt J; Metz A; Barthel T; Lima GMA; Heine A; Mueller U; Klebe G; Weiss MS Structure; 2020 Jun; 28(6):694-706.e5. PubMed ID: 32413289 [TBL] [Abstract][Full Text] [Related]
12. Screening Ligands by X-ray crystallography. Davies DR Methods Mol Biol; 2014; 1140():315-23. PubMed ID: 24590727 [TBL] [Abstract][Full Text] [Related]
13. Automated crystal mounting and data collection for protein crystallography. Muchmore SW; Olson J; Jones R; Pan J; Blum M; Greer J; Merrick SM; Magdalinos P; Nienaber VL Structure; 2000 Dec; 8(12):R243-6. PubMed ID: 11188700 [TBL] [Abstract][Full Text] [Related]
14. In-plate protein crystallization, in situ ligand soaking and X-ray diffraction. le Maire A; Gelin M; Pochet S; Hoh F; Pirocchi M; Guichou JF; Ferrer JL; Labesse G Acta Crystallogr D Biol Crystallogr; 2011 Sep; 67(Pt 9):747-55. PubMed ID: 21904027 [TBL] [Abstract][Full Text] [Related]
15. Predicting the success of fragment screening by X-ray crystallography. Davies DR; Begley DW; Hartley RC; Staker BL; Stewart LJ Methods Enzymol; 2011; 493():91-114. PubMed ID: 21371588 [TBL] [Abstract][Full Text] [Related]
16. Frag4Lead: growing crystallographic fragment hits by catalog using fragment-guided template docking. Metz A; Wollenhaupt J; Glöckner S; Messini N; Huber S; Barthel T; Merabet A; Gerber HD; Heine A; Klebe G; Weiss MS Acta Crystallogr D Struct Biol; 2021 Sep; 77(Pt 9):1168-1182. PubMed ID: 34473087 [TBL] [Abstract][Full Text] [Related]
17. Combining 'dry' co-crystallization and in situ diffraction to facilitate ligand screening by X-ray crystallography. Gelin M; Delfosse V; Allemand F; Hoh F; Sallaz-Damaz Y; Pirocchi M; Bourguet W; Ferrer JL; Labesse G; Guichou JF Acta Crystallogr D Biol Crystallogr; 2015 Aug; 71(Pt 8):1777-87. PubMed ID: 26249358 [TBL] [Abstract][Full Text] [Related]
18. A comprehensive approach to X-ray crystallography for drug discovery at a synchrotron facility - The example of Diamond Light Source. Mazzorana M; Shotton EJ; Hall DR Drug Discov Today Technol; 2020 Dec; 37():83-92. PubMed ID: 34895658 [TBL] [Abstract][Full Text] [Related]
19. Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source. Douangamath A; Powell A; Fearon D; Collins PM; Talon R; Krojer T; Skyner R; Brandao-Neto J; Dunnett L; Dias A; Aimon A; Pearce NM; Wild C; Gorrie-Stone T; von Delft F J Vis Exp; 2021 May; (171):. PubMed ID: 34125095 [TBL] [Abstract][Full Text] [Related]
20. Preparation and Delivery of Protein Microcrystals in Lipidic Cubic Phase for Serial Femtosecond Crystallography. Ishchenko A; Cherezov V; Liu W J Vis Exp; 2016 Sep; (115):. PubMed ID: 27683972 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]